Clinical Trial Update: DOAC - Dosing Options in AntiCoagulation Prophylaxis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating dosing options of direct oral anticoagulants for anti-coagulation prophylaxis in cancer-associated venous thromboembolism; currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Venous Thromboembolism

Snippet

Sponsor: University of Vermont | Conditions: Cancer, VTE (Venous Thromboembolism) | Phase 3 | Status: RECRUITING